Methyl 4-(1-methoxy-1-oxopent-4-yn-2-yl)benzoate, 97%, 1g

2-Methylquinoline-6-carbaldehyde, 95.0%, 10g

2-(Iodomethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

Methyl 2-formyl-1H-indole-5-carboxylate, 97.0%, 100mg

Sodium dibenzylcarbamodithioate, 95%, 25g

8-Amino-6-bromoimidazol[1,2-a]pyrazine, 95.0%, 250mg

1-(2-Pyridylazo)-2-naphtol, min 98%, pa, ACS, 1 g, emballage verre

2-Amino-5-bromophenol, 97.0%, 5g

(S)-2-(Benzo[b]thiophen-2-yl)-4-benzyl-4,5-dihydrooxazole, 97%, 1g

Flacons à centrifuger avec fermeture étanche Type 3141, 250 ml, 250 ml, 4 pièce(s)

(1R,2R,3R,4S,5R,6S,7S,8S)-methyl 4-bromocubane-1-carboxylate, 98%, 1g

1-(2,3-Difluorobenzyl)piperidin-4-aminedihydrochloride, 95.0%, 1g

3-Bromo-2,4-difluoropyridine, 95.0%, 250mg